Results 91 to 100 of about 21,247 (273)
This article explores headache as a common yet underrecognized symptom of Moyamoya angiopathy (MMA), affecting up to 75% of patients. It reviews the potential pathophysiological mechanisms, including impaired autoregulation and microvascular ischemia, and discusses current and emerging treatment strategies, such as revascularization surgery and CGRP ...
Nicola Rifino+8 more
wiley +1 more source
Moyamoya disease (MMD) is a unique cerebrovascular disease characterized initially by an obliterative vasculopathy followed by a compensatory proliferative vasculopathy. Coined by Suzuki and Takaku in 1969, the term moyamoya (MM) refers to a “puff of smoke” like appearance of small collaterals seen traversing the basal ganglia and thalamus, in response
Girish Menon, Ajay Hegde
openaire +2 more sources
Moyamoya Disease in Europeans [PDF]
Background and Purpose— We describe the clinical, diagnostic, and outcome features of a cohort of white patients with idiopathic moyamoya disease treated in a German institution. Methods— Our cohort included 21 white patients ...
Peter Berlit+2 more
openaire +3 more sources
Spontaanne Willisi ringi oklusioon ehk morbus moyamoya [PDF]
Kirjeldatud on intratserebraalse hemorraagia juhtu 15aastasel noormehel, kellel diagnoositi spontaanset Willisi ringi oklusiooni ehk moyamoya haigust. Meie teada on see esimene haigusjuhu kirjeldus Eestis.
Asser, Toomas, Vaher, Ando
core +2 more sources
Angiographic Characteristics and Progression in A Comprehensive Nationwide European MOYAMOYA Cohort
Findings from the review of radiologic studies within a Danish nationwide cohort of 50 patients diagnosed with Moyamoya disease (MMD) do not support the idea of a distinct European MDD subtype. About 34% of cases showed angiographic progression, and there was a trend towards a higher stroke risk in patients with angiographic progression.
Peter Birkeland+5 more
wiley +1 more source
Differentiation, Evaluation, and Application of Human Induced Pluripotent Stem Cell–Derived Endothelial Cells [PDF]
The emergence of induced pluripotent stem cell (iPSC) technology paves the way to generate large numbers of patient-specific endothelial cells (ECs) that can be potentially delivered for regenerative medicine in patients with cardiovascular disease.
Gil, Chang-Hyun+2 more
core +1 more source
Intracranial stenting with the Neuroform Atlas stent is a potentially safe and effective treatment for symptomatic intracranial atherosclerotic stenosis (sICAS). It demonstrates a statistically significant difference in the caliber of the target artery before and after treatment as well as significantly improves the cerebral ischemic symptoms of ...
Weicheng Peng+9 more
wiley +1 more source
ABSTRACT This case highlights that calcified chronic subdural hematoma (CCSDH) may induce adjacent cranial thickening due to chronic cerebral hypoperfusion and metabolic disturbances. Surgical resection can be performed safely, but psychiatric symptoms (e.g., depression, insomnia) may persist postoperatively, suggesting they are not always hematoma ...
Xiaoyong Yang+3 more
wiley +1 more source
We observed significant differences in the distribution of unruptured intracranial aneurysm (UIA) between the vestibular migraine (VM) and migraine groups compared to the control group. Furthermore, intergroup comparisons of morphological parameters indicated that both VM (non‐spherical index) and migraine (age) patients have a higher risk of aneurysm ...
Yaoheng Zhang+8 more
wiley +1 more source
Moyamoya Syndrome, Epilepsy and Hydrocephalus in Neurofibromatosis Type 1
ABSTRACT Background Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous syndrome. NF1‐related vasculopathy represents a clinically significant yet underrecognized complication. Moyamoya syndrome, a rare cerebrovascular manifestation of NF1, has been rarely reported in the paediatric population.
Fen Zhao+3 more
wiley +1 more source